Biomarker Feedback to Motivate Tobacco Cessation in Pregnant ALaska Native Women: Phase 2

Completed

Conditions studied: Cancer, Tobacco Use, Pregnancy

In brief

Use of tobacco is very high among Alaska Native pregnant women. The investigators are conducting a three phase study. The first study is nearly completed and involved measuring biomarkers of tobacco exposure in mothers and infants. The second phase of the research is a qualitative study to translate the biomarker findings to an intervention.

Key facts

Study ID

NCT02018640

Run by

Mayo Clinic

People needed

39

Starts

2013-12-01

Expected to finish

2015-08-01

Last updated by the study team

2017-12-19

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• To be eligible the woman must:
• be Alaska Native
• be aged 18 years of age or older
• provide written informed consent
• have participated in Phase 1 of the research or is currently pregnant (<= 24 weeks gestation)
• have used any tobacco product at least once in the past 7 days (cigarettes or both cigarettes/ST)
• To be eligible the confidant (he/she) must:
• be referred by the woman participant
• be aged 18 years of age or older
• provide written informed consent

You may not qualify if…

• does not provide written informed consent

Where it is running

• Alaska Native Tribal Health Consortium — Anchorage, Alaska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.